Citation

Tyshenko MG. Bioethics 2007; 21(7): 364-369.

Affiliation

University of Ottawa, Ottawa, Canada. mtyshenk@uottawa.ca

Copyright

(Copyright © 2007, John Wiley and Sons)

DOI

10.1111/j.1467-8519.2007.00571.x

PMID

17845462

Abstract

A recent approach for bioterrorism risk management calls for stricter regulations over biotechnology as a way to control subversion of technology that may be used to create a man-made pandemic. This approach is largely unworkable given the increasing pervasiveness of molecular techniques and tools throughout society. Emerging technology has provided the tools to design much deadlier pathogens but concomitantly the ability to respond to emerging pandemics to reduce mortality has also improved significantly in recent decades. In its historical context determining just how 'risky' biological weapons is an important consideration for decision making and resource allocation. Management should attempt to increase capacity, share resources, provide accurate infectious disease reporting, deliver information transparency and improve communications to help mitigate the magnitude of future pandemics.

Language: en